P572 Reactive dose escalation of infliximab in patients with Crohn’s disease in TAILORIX leads to improved outcomes
2018 ◽
Vol 12
(supplement_1)
◽
pp. S396-S397
2018 ◽
Vol 12
(supplement_1)
◽
pp. S314-S314
Keyword(s):
2017 ◽
Vol 2
(4)
◽
pp. 228-235
◽
Keyword(s):
2014 ◽
Vol 20
(1)
◽
pp. 214
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 3
(1)
◽
pp. 29229
◽